(-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma.

Breast Cancer Res · 2010 · PMC2880428 · PMID 20078855

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

marginally significantP = 0.053so close (0.05 < p ≤ 0.1)

There was no significant difference between the control group and taxol- or EGCG-treated group, while the difference between the control group and combination treatment group was marginally significant ( P = 0.053).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.